{"id":"https://openalex.org/W2979806580","doi":"https://doi.org/10.1039/c9lc00519f","title":"Drug-induced skin toxicity: gaps in preclinical testing cascade as opportunities for complex in vitro models and assays","display_name":"Drug-induced skin toxicity: gaps in preclinical testing cascade as opportunities for complex in vitro models and assays","alternate_titles":[],"publication_year":2020,"publication_date":"2020-01-21","ids":{"openalex":"https://openalex.org/W2979806580","doi":"https://doi.org/10.1039/c9lc00519f","mag":"2979806580","pmid":"https://pubmed.ncbi.nlm.nih.gov/31598618"},"language":"en","primary_location":{"id":"doi:10.1039/c9lc00519f","doi":"https://doi.org/10.1039/c9lc00519f","is_oa":false,"landing_page_url":"https://doi.org/10.1039/c9lc00519f","pdf_url":null,"source":{"id":"https://openalex.org/S116836101","display_name":"Lab on a Chip","issn_l":"1473-0189","issn":["1473-0189","1473-0197"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320556","host_organization_name":"Royal Society of Chemistry","host_organization_lineage":["https://openalex.org/P4310320556"],"host_organization_lineage_names":["Royal Society of Chemistry"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Lab on a Chip","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2979806580"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5043889674","display_name":"Rhiannon N. Hardwick","orcid":"https://orcid.org/0000-0001-9052-1309","observed_orcids":["https://orcid.org/0000-0001-9052-1309"]},"institutions":[{"id":"https://openalex.org/I4210133216","display_name":"Theravance Biopharma (United States)","ror":"https://ror.org/03a6z4w08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210133216"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Rhiannon N. Hardwick","raw_affiliation_strings":["South San Francisco","Theravance Biopharma, US, Inc","Translational Safety Sciences","USA","Translational Safety Sciences, Theravance Biopharma, US, Inc., South San Francisco, CA, USA"],"raw_orcid":"https://orcid.org/0000-0001-9052-1309","affiliations":[{"raw_affiliation_string":"South San Francisco","institution_ids":[]},{"raw_affiliation_string":"Theravance Biopharma, US, Inc","institution_ids":["https://openalex.org/I4210133216"]},{"raw_affiliation_string":"Translational Safety Sciences","institution_ids":[]},{"raw_affiliation_string":"USA","institution_ids":[]},{"raw_affiliation_string":"Translational Safety Sciences, Theravance Biopharma, US, Inc., South San Francisco, CA, USA","institution_ids":["https://openalex.org/I4210133216"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111686370","display_name":"Catherine Jean Betts","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Catherine J. Betts","raw_affiliation_strings":["AstraZeneca","Cambridge","Drug Safety and Metabolism","IMED Biotech Unit","Pathology Sciences","Pathology Sciences, Drug Safety and Metabolism, IMED Biotech Unit, AstraZeneca, Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca","institution_ids":["https://openalex.org/I105036370"]},{"raw_affiliation_string":"Cambridge","institution_ids":[]},{"raw_affiliation_string":"Drug Safety and Metabolism","institution_ids":[]},{"raw_affiliation_string":"IMED Biotech Unit","institution_ids":[]},{"raw_affiliation_string":"Pathology Sciences","institution_ids":[]},{"raw_affiliation_string":"Pathology Sciences, Drug Safety and Metabolism, IMED Biotech Unit, AstraZeneca, Cambridge, UK","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030126076","display_name":"Jessica Whritenour","orcid":"https://orcid.org/0000-0001-5843-2461","observed_orcids":["https://orcid.org/0000-0001-5843-2461"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jessica Whritenour","raw_affiliation_strings":["Drug Safety Research and Development","Groton","Pfizer, Inc","USA","Pfizer, Inc., Drug Safety Research and Development, Eastern Point Rd, Groton, CT 06340, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Safety Research and Development","institution_ids":[]},{"raw_affiliation_string":"Groton","institution_ids":[]},{"raw_affiliation_string":"Pfizer, Inc","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"USA","institution_ids":[]},{"raw_affiliation_string":"Pfizer, Inc., Drug Safety Research and Development, Eastern Point Rd, Groton, CT 06340, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000985393","display_name":"Radhakrishna Sura","orcid":"https://orcid.org/0000-0001-6337-5588","observed_orcids":["https://orcid.org/0000-0001-6337-5588"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Radhakrishna Sura","raw_affiliation_strings":["Abbvie Inc","North Chicago","Preclinical Safety","USA","Preclinical Safety, Abbvie Inc., North Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abbvie Inc","institution_ids":["https://openalex.org/I2948539688"]},{"raw_affiliation_string":"North Chicago","institution_ids":[]},{"raw_affiliation_string":"Preclinical Safety","institution_ids":[]},{"raw_affiliation_string":"USA","institution_ids":[]},{"raw_affiliation_string":"Preclinical Safety, Abbvie Inc., North Chicago, IL, USA","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064337257","display_name":"Maike Thamsen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133216","display_name":"Theravance Biopharma (United States)","ror":"https://ror.org/03a6z4w08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210133216"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Maike Thamsen","raw_affiliation_strings":["Pharmacology","South San Francisco","Theravance Biopharma, US, Inc","USA","Pharmacology, Theravance Biopharma, US, Inc., South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacology","institution_ids":[]},{"raw_affiliation_string":"South San Francisco","institution_ids":[]},{"raw_affiliation_string":"Theravance Biopharma, US, Inc","institution_ids":["https://openalex.org/I4210133216"]},{"raw_affiliation_string":"USA","institution_ids":[]},{"raw_affiliation_string":"Pharmacology, Theravance Biopharma, US, Inc., South San Francisco, CA, USA","institution_ids":["https://openalex.org/I4210133216"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112137819","display_name":"Elad Kaufman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133216","display_name":"Theravance Biopharma (United States)","ror":"https://ror.org/03a6z4w08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210133216"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Elad H. Kaufman","raw_affiliation_strings":["Biology","South San Francisco","Theravance Biopharma, US, Inc","USA","Biology, Theravance Biopharma, US, Inc., South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biology","institution_ids":[]},{"raw_affiliation_string":"South San Francisco","institution_ids":[]},{"raw_affiliation_string":"Theravance Biopharma, US, Inc","institution_ids":["https://openalex.org/I4210133216"]},{"raw_affiliation_string":"USA","institution_ids":[]},{"raw_affiliation_string":"Biology, Theravance Biopharma, US, Inc., South San Francisco, CA, USA","institution_ids":["https://openalex.org/I4210133216"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5019711875","display_name":"Kristin M. Fabre","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]},{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["GB","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kristin Fabre","raw_affiliation_strings":["AstraZeneca","Drug Safety & Metabolism","IMED Biotech Unit","MPS Center of Excellence","Waltham","MPS Center of Excellence, Drug Safety & Metabolism, IMED Biotech Unit, AstraZeneca, Waltham, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca","institution_ids":["https://openalex.org/I105036370"]},{"raw_affiliation_string":"Drug Safety & Metabolism","institution_ids":[]},{"raw_affiliation_string":"IMED Biotech Unit","institution_ids":[]},{"raw_affiliation_string":"MPS Center of Excellence","institution_ids":[]},{"raw_affiliation_string":"Waltham","institution_ids":[]},{"raw_affiliation_string":"MPS Center of Excellence, Drug Safety & Metabolism, IMED Biotech Unit, AstraZeneca, Waltham, MA, USA","institution_ids":["https://openalex.org/I4210150756"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5043889674"],"corresponding_institution_ids":["https://openalex.org/I4210133216"],"apc_list":null,"apc_paid":null,"fwci":0.6129,"has_fulltext":false,"cited_by_count":55,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.49585163,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":97,"max":99},"biblio":{"volume":"20","issue":"2","first_page":"199","last_page":"214"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11190","display_name":"3D Printing in Biomedical Research","score":0.9032999873161316,"subfield":{"id":"https://openalex.org/subfields/2204","display_name":"Biomedical Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11190","display_name":"3D Printing in Biomedical Research","score":0.9032999873161316,"subfield":{"id":"https://openalex.org/subfields/2204","display_name":"Biomedical Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12281","display_name":"Animal testing and alternatives","score":0.026599999517202377,"subfield":{"id":"https://openalex.org/subfields/3404","display_name":"Small Animals"},"field":{"id":"https://openalex.org/fields/34","display_name":"Veterinary"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11033","display_name":"Contact Dermatitis and Allergies","score":0.01720000058412552,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/drug-induced-skin-toxicity","display_name":"drug-induced skin toxicity","score":0.9940000176429749},{"id":"https://openalex.org/keywords/microphysiological-systems","display_name":"microphysiological systems","score":0.9789999723434448},{"id":"https://openalex.org/keywords/organ-on-a-chip","display_name":"organ-on-a-chip","score":0.875},{"id":"https://openalex.org/keywords/skin-organoids","display_name":"skin organoids","score":0.7850000262260437},{"id":"https://openalex.org/keywords/skin-irritation","display_name":"skin irritation","score":0.5189999938011169},{"id":"https://openalex.org/keywords/skin-corrosion","display_name":"skin corrosion","score":0.6610000133514404},{"id":"https://openalex.org/keywords/skin-sensitization","display_name":"skin sensitization","score":0.8330000042915344},{"id":"https://openalex.org/keywords/skin-absorption","display_name":"percutaneous absorption","score":0.6579999923706055},{"id":"https://openalex.org/keywords/phototoxicity","display_name":"phototoxicity","score":0.9879999756813049},{"id":"https://openalex.org/keywords/genotoxicity","display_name":"genotoxicity","score":0.968999981880188},{"id":"https://openalex.org/keywords/hair-follicle","display_name":"hair follicle","score":0.6679999828338623},{"id":"https://openalex.org/keywords/innervation","display_name":"innervation","score":0.5989999771118164},{"id":"https://openalex.org/keywords/drug-development","display_name":"drug development","score":0.7739999890327454}],"concepts":[{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.665981650352478},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.6212377548217773},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.5750126838684082},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5445578098297119},{"id":"https://openalex.org/C34146451","wikidata":"https://www.wikidata.org/wiki/Q5048094","display_name":"Cascade","level":2,"score":0.5422902703285217},{"id":"https://openalex.org/C2994543053","wikidata":"https://www.wikidata.org/wiki/Q7239206","display_name":"Preclinical testing","level":2,"score":0.5399506092071533},{"id":"https://openalex.org/C33618052","wikidata":"https://www.wikidata.org/wiki/Q6013136","display_name":"In vitro toxicology","level":3,"score":0.4499715566635132},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.4309535622596741},{"id":"https://openalex.org/C2992092908","wikidata":"https://www.wikidata.org/wiki/Q45959","display_name":"Drug toxicity","level":3,"score":0.42404884099960327},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.3519137501716614},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3460233807563782},{"id":"https://openalex.org/C183696295","wikidata":"https://www.wikidata.org/wiki/Q2487696","display_name":"Biochemical engineering","level":1,"score":0.33973199129104614},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.29607275128364563},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.246250182390213},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.21514567732810974},{"id":"https://openalex.org/C19527891","wikidata":"https://www.wikidata.org/wiki/Q1120908","display_name":"Medical physics","level":1,"score":0.1406492292881012},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.08033448457717896},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.061270445585250854},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000076722","descriptor_name":"Drug Development","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004345","descriptor_name":"Drug Industry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004364","descriptor_name":"Pharmaceutical Preparations","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008954","descriptor_name":"Models, Biological","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D012867","descriptor_name":"Skin","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D056656","descriptor_name":"Lab-On-A-Chip Devices","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1039/c9lc00519f","doi":"https://doi.org/10.1039/c9lc00519f","is_oa":false,"landing_page_url":"https://doi.org/10.1039/c9lc00519f","pdf_url":null,"source":{"id":"https://openalex.org/S116836101","display_name":"Lab on a Chip","issn_l":"1473-0189","issn":["1473-0189","1473-0197"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320556","host_organization_name":"Royal Society of Chemistry","host_organization_lineage":["https://openalex.org/P4310320556"],"host_organization_lineage_names":["Royal Society of Chemistry"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Lab on a Chip","raw_type":"journal-article"},{"id":"pmid:31598618","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31598618","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Lab on a chip","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8371999859809875,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":80,"referenced_works":["https://openalex.org/W154470822","https://openalex.org/W233821363","https://openalex.org/W1210654754","https://openalex.org/W1530507248","https://openalex.org/W1584888609","https://openalex.org/W1681939708","https://openalex.org/W1912543522","https://openalex.org/W1951261947","https://openalex.org/W1963798164","https://openalex.org/W1963928215","https://openalex.org/W1969064295","https://openalex.org/W1971154737","https://openalex.org/W1972398615","https://openalex.org/W1973806783","https://openalex.org/W1978350956","https://openalex.org/W1979450562","https://openalex.org/W1981947786","https://openalex.org/W1986338215","https://openalex.org/W1996967496","https://openalex.org/W1998816898","https://openalex.org/W2003302711","https://openalex.org/W2012510931","https://openalex.org/W2013316831","https://openalex.org/W2017576139","https://openalex.org/W2019855029","https://openalex.org/W2034419363","https://openalex.org/W2034470052","https://openalex.org/W2034810440","https://openalex.org/W2044733423","https://openalex.org/W2054865262","https://openalex.org/W2057098942","https://openalex.org/W2062243517","https://openalex.org/W2063147800","https://openalex.org/W2066577674","https://openalex.org/W2071282917","https://openalex.org/W2072518056","https://openalex.org/W2076468258","https://openalex.org/W2084641827","https://openalex.org/W2085790896","https://openalex.org/W2090321152","https://openalex.org/W2092750645","https://openalex.org/W2112335880","https://openalex.org/W2118994197","https://openalex.org/W2122089925","https://openalex.org/W2154399479","https://openalex.org/W2202304672","https://openalex.org/W2265285917","https://openalex.org/W2271930197","https://openalex.org/W2280309383","https://openalex.org/W2291170163","https://openalex.org/W2402417130","https://openalex.org/W2403619724","https://openalex.org/W2471536144","https://openalex.org/W2501169448","https://openalex.org/W2517221571","https://openalex.org/W2547035301","https://openalex.org/W2584961612","https://openalex.org/W2592142086","https://openalex.org/W2618816971","https://openalex.org/W2768926280","https://openalex.org/W2770248284","https://openalex.org/W2785046802","https://openalex.org/W2785747601","https://openalex.org/W2790974974","https://openalex.org/W2793163074","https://openalex.org/W2800257361","https://openalex.org/W2884143739","https://openalex.org/W2884948137","https://openalex.org/W2887146945","https://openalex.org/W2887183837","https://openalex.org/W2911588153","https://openalex.org/W3123784365","https://openalex.org/W4235197675","https://openalex.org/W4242401595","https://openalex.org/W4243361639","https://openalex.org/W4247390740","https://openalex.org/W4247720250","https://openalex.org/W4252420919","https://openalex.org/W4254232717","https://openalex.org/W4256006855"],"related_works":["https://openalex.org/W4386686202","https://openalex.org/W2888887788","https://openalex.org/W2336283883","https://openalex.org/W4401486232","https://openalex.org/W3039284679","https://openalex.org/W4382345046","https://openalex.org/W2517221571","https://openalex.org/W7223379995","https://openalex.org/W4391914505","https://openalex.org/W2766752161"],"abstract_inverted_index":{"Skin":[0],"is":[1,76],"the":[2,6,11,15,78,163,179,188],"largest":[3],"organ":[4,81],"of":[5,18,49,103,112,138,154,185],"body":[7],"and":[8,33,67,87,94,107,114,126,145,160,167,173],"serves":[9,31],"as":[10,122,141],"principle":[12],"barrier":[13],"to":[14,39,59,84,95,181],"environment.":[16],"Composed":[17],"multiple":[19],"cell":[20],"types":[21],"arranged":[22],"in":[23,37,46],"stratified":[24],"layers":[25],"with":[26,82,178],"highly":[27],"specialized":[28],"appendages,":[29],"it":[30],"sensory":[32],"immune":[34,135],"surveillance":[35],"roles":[36],"addition":[38],"its":[40],"primary":[41],"mechanical":[42],"function.":[43],"Several":[44],"complex":[45,104,156],"vitro":[47],"models":[48,106],"skin":[50,75,105,157],"(i.e.":[51],"microphysiological":[52],"systems":[53],"(MPS)":[54],"including":[55,91],"but":[56],"not":[57],"limited":[58],"3D":[60],"tissues,":[61],"organ-on-a-chip,":[62],"organoids),":[63],"have":[64],"been":[65],"developed":[66],"assays":[68,109],"validated":[69],"for":[70,110,134,169],"regulatory":[71],"purposes.":[72],"As":[73],"such,":[74],"arguably":[77],"most":[79],"advanced":[80],"respect":[83],"model":[85,158,171],"development":[86,165,172],"adoption":[88,102,184],"across":[89],"industries":[90],"chemical,":[92],"cosmetic,":[93],"a":[96],"somewhat":[97],"lesser":[98],"extent,":[99],"pharmaceutical.":[100],"Early":[101],"associated":[108],"assessment":[111],"irritation":[113],"corrosion":[115],"spurred":[116],"research":[117],"into":[118],"other":[119],"areas":[120],"such":[121,129,140],"sensitization,":[123],"absorption,":[124],"phototoxicity,":[125],"genotoxicity.":[127],"Despite":[128],"considerable":[130],"advancements,":[131],"opportunities":[132],"remain":[133],"capabilities,":[136],"inclusion":[137],"appendages":[139],"hair":[142],"follicles,":[143],"fluidics,":[144],"innervation,":[146],"among":[147],"others.":[148],"Herein,":[149],"we":[150],"provide":[151],"an":[152],"overview":[153],"current":[155],"capabilities":[159],"limitations":[161],"within":[162,187],"drug":[164],"scheme,":[166],"recommendations":[168],"future":[170],"assay":[174],"qualification":[175],"and/or":[176],"validation":[177],"intent":[180],"facilitate":[182],"wider":[183],"use":[186],"pharmaceutical":[189],"industry.":[190]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2979806580","counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":9},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":12},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":10},{"year":2020,"cited_by_count":5}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2019-10-18T00:00:00"}
